Search by Drug Name or NDC
NDC 00078-0925-25 Maxidex 1 mg/mL Details
Maxidex 1 mg/mL
Maxidex is a OPHTHALMIC SUSPENSION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is DEXAMETHASONE.
MedlinePlus Drug Summary
Dexamethasone reduces the irritation, redness, burning, and swelling of eye caused by chemicals, heat, radiation, infection, allergy, or foreign bodies in the eye. It is sometimes used after eye surgery.
Related Packages: 00078-0925-25Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Dexamethasone Ophthalmic
Product Information
| NDC | 00078-0925 |
|---|---|
| Product ID | 0078-0925_eff2947a-9faa-4206-b11a-9ba2fbb7da43 |
| Associated GPIs | |
| GCN Sequence Number | 007900 |
| GCN Sequence Number Description | dexamethasone DROPS SUSP 0.1 % OPHTHALMIC |
| HIC3 | Q6P |
| HIC3 Description | EYE ANTI-INFLAMMATORY AGENTS |
| GCN | 41950 |
| HICL Sequence Number | 002889 |
| HICL Sequence Number Description | DEXAMETHASONE |
| Brand/Generic | Brand |
| Proprietary Name | Maxidex |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | dexamethasone |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SUSPENSION/ DROPS |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | mg/mL |
| Substance Name | DEXAMETHASONE |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Pharmaceutical Class | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA013422 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00078-0925-25 (00078092525)
| NDC Package Code | 0078-0925-25 |
|---|---|
| Billing NDC | 00078092525 |
| Package | 5 mL in 1 BOTTLE (0078-0925-25) |
| Marketing Start Date | 2022-07-05 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 16.5916 |
| Pricing Unit | ML |
| Effective Date | 2023-05-17 |
| NDC Description | MAXIDEX 0.1% EYE DROPS |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis